[1]
“Treatment of severe acute respiratory syndrome caused by Sars-Cov-2 virus with Angiotensin II receptor blockers”, Acervo Saúde, vol. 13, no. 8, p. e8506, Aug. 2021, doi: 10.25248/reas.e8506.2021.